Blueprint Genetics is taking part in the 13th International Conference on Osteogenesis Imperfecta in Oslo.
The conference provides an international forum for the presentation and discussion of current basic and clinical science in the field of osteogenesis imperfecta in children, adolescents and adults.
At the conclusion of this program:
- Clinicians will be able to develop a multidisciplinary management plan for children, adolescents and adults with OI.
- Participants will be able to discuss the latest research in the surgical, therapeutic and medical management of OI.
- Clinicians will be able to deliver evidence-based surgical and therapeutic care for their patients with OI.
- Participants will be aware of the non-medical resources available to OI patients, and be able to share those resources appropriately with patients.